300601SZSE
🚨 Material Event

Shenzhen Kangtai Biological Products Co., Ltd. 2026 First Extraordinary General Meeting Resolution Announcement

✨ AI Summary

The company held its first extraordinary general meeting on August 21, 2026. The proposal to lower the conversion price of "Kangtai Convertible Bond 2" and a commitment not to propose further lowering was not passed due to a majority of opposing votes. The meeting was convened and held in compliance with relevant laws and regulations.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 300601

Bond Code: 123119

Securities Abbreviation: Kangtai Biological

Bond Abbreviation: Kangtai Convertible 2

Announcement Number: 2026-058

Shenzhen Kangtai Biological Products Co., Ltd.

Announcement of Resolutions from the First Extraordinary General Meeting in 2026

The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.

Special Notes:

  1. The following situation occurred regarding the voting on proposals at this shareholder meeting: The Company received a "Letter of Explanation" from Mr. Du Weimin, the controlling shareholder. Due to significant stock price fluctuations on the trading day prior to the shareholder meeting, which differed greatly from the situation when the Board proposed this resolution, an opposing vote was cast on this proposal at the shareholder meeting.

  2. This shareholder meeting did not involve any changes to previous shareholder meeting resolutions.

  3. This shareholder meeting was convened using a combination of on-site voting and online voting.

I. Meeting Convening Situation

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.